Changes

{{Top|author1=[[User:Mikael Häggström|Mikael Häggström]]|author2=}}<noinclude>{{Bottom}}</noinclude>In neoadjuvant cases, measure:

*Classification of '''residual cancer''', for which there are multiple systems, mainly ''Residual Cancer Burden'' (RCB)<ref group=notes>A calculator and explanations for calculating RCB is found at: http://www3.mdanderson.org/app/medcalc/index.cfm?pagename=jsconvert3</ref> and the American Joint Committee on Cancer post-neoadjuvant therapy staging system (yAJCC).<ref name="pmid28577078">{{cite journal| author=Campbell JI, Yau C, Krass P, Moore D, Carey LA, Au A | display-authors=etal| title=Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). | journal=Breast Cancer Res Treat | year= 2017 | volume= 165 | issue= 1 | pages= 181-191 | pmid=28577078 | doi=10.1007/s10549-017-4303-8 | pmc=5653207 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28577078 }} </ref><noinclude>{{Bottom}}</noinclude>